drugset / Trial / NCT02478281

Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

NCT02478281

Phase 1 Completed 12 enrolled American Regent, Inc.
NaSingle-groupOpen-labelTreatment

Summary

A Phase 1 trial to assess the single-dose safety, tolerability, and pharmacokinetic (PK) of Methylene Blue Injection, USP 1 mg/kg in healthy adult volunteers.

Timeline

Start
2012-10
Primary completion
2012-10
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent 1 mg/kg Intravenous